These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

162 related items for PubMed ID: 36799619

  • 21. Targeting macrophage Syk enhances responses to immune checkpoint blockade and radiotherapy in high-risk neuroblastoma.
    Rohila D, Park IH, Pham TV, Jones R, Tapia E, Liu KX, Tamayo P, Yu A, Sharabi AB, Joshi S.
    Front Immunol; 2023; 14():1148317. PubMed ID: 37350973
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Combination of ultrasound-based mechanical disruption of tumor with immune checkpoint blockade modifies tumor microenvironment and augments systemic antitumor immunity.
    Abe S, Nagata H, Crosby EJ, Inoue Y, Kaneko K, Liu CX, Yang X, Wang T, Acharya CR, Agarwal P, Snyder J, Gwin W, Morse MA, Zhong P, Lyerly HK, Osada T.
    J Immunother Cancer; 2022 Jan; 10(1):. PubMed ID: 35039461
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Poor clinical outcomes of intratumoral dendritic cell-specific intercellular adhesion molecule 3-grabbing non-integrin-positive macrophages associated with immune evasion in gastric cancer.
    Liu X, Cao Y, Li R, Gu Y, Chen Y, Qi Y, Lv K, Wang J, Yu K, Lin C, Liu H, Zhang H, He H, Chen L, Zhang P, Shen Z, Qin J, Sun Y, Li H, Huang H, Zhang W, Xu J.
    Eur J Cancer; 2020 Mar; 128():27-37. PubMed ID: 32109848
    [Abstract] [Full Text] [Related]

  • 29. Delicaflavone reactivates anti-tumor immune responses by abrogating monocytic myeloid cell-mediated immunosuppression.
    Li L, You W, Wang X, Zou Y, Yao H, Lan H, Lin X, Zhang Q, Chen B.
    Phytomedicine; 2023 Jan; 108():154508. PubMed ID: 36332384
    [Abstract] [Full Text] [Related]

  • 30. Single-cell RNA sequencing reveals compartmental remodeling of tumor-infiltrating immune cells induced by anti-CD47 targeting in pancreatic cancer.
    Pan Y, Lu F, Fei Q, Yu X, Xiong P, Yu X, Dang Y, Hou Z, Lin W, Lin X, Zhang Z, Pan M, Huang H.
    J Hematol Oncol; 2019 Nov 27; 12(1):124. PubMed ID: 31771616
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Characterization of Immunosuppressive Myeloid Cells in Merkel Cell Carcinoma: Correlation with Resistance to PD-1 Pathway Blockade.
    Tabachnick-Cherny S, Pulliam T, Rodriguez HJ, Fan X, Hippe DS, Jones DC, Moshiri AS, Smythe KS, Kulikauskas RM, Zaba LC, Paulson KG, Nghiem P.
    Clin Cancer Res; 2024 Mar 15; 30(6):1189-1199. PubMed ID: 37851052
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Improving radiotherapy in immunosuppressive microenvironments by targeting complement receptor C5aR1.
    Beach C, MacLean D, Majorova D, Melemenidis S, Nambiar DK, Kim RK, Valbuena GN, Guglietta S, Krieg C, Darvish-Damavandi M, Suwa T, Easton A, Hillson LV, McCulloch AK, McMahon RK, Pennel K, Edwards J, O'Cathail SM, Roxburgh CS, Domingo E, Moon EJ, Jiang D, Jiang Y, Zhang Q, Koong AC, Woodruff TM, Graves EE, Maughan T, Buczacki SJ, Stucki M, Le QT, Leedham SJ, Giaccia AJ, Olcina MM.
    J Clin Invest; 2023 Dec 01; 133(23):. PubMed ID: 37824211
    [Abstract] [Full Text] [Related]

  • 35. ICOS costimulation in combination with CTLA-4 blockade remodels tumor-associated macrophages toward an antitumor phenotype.
    Sharma N, Fan X, Atolagbe OT, Ge Z, Dao KN, Sharma P, Allison JP.
    J Exp Med; 2024 Apr 01; 221(4):. PubMed ID: 38517331
    [Abstract] [Full Text] [Related]

  • 36. Blockade of C5aR1 resets M1 via gut microbiota-mediated PFKM stabilization in a TLR5-dependent manner.
    Zhao J, Yao C, Qin Y, Zhu H, Guo H, Ji B, Li X, Sun N, Li R, Wu Y, Zheng K, Pan Y, Zhao T, Yang J.
    Cell Death Dis; 2024 Feb 08; 15(2):120. PubMed ID: 38331868
    [Abstract] [Full Text] [Related]

  • 37. Tumor cell-released autophagosomes (TRAPs) promote immunosuppression through induction of M2-like macrophages with increased expression of PD-L1.
    Wen ZF, Liu H, Gao R, Zhou M, Ma J, Zhang Y, Zhao J, Chen Y, Zhang T, Huang F, Pan N, Zhang J, Fox BA, Hu HM, Wang LX.
    J Immunother Cancer; 2018 Dec 18; 6(1):151. PubMed ID: 30563569
    [Abstract] [Full Text] [Related]

  • 38. Progranulin induces immune escape in breast cancer via up-regulating PD-L1 expression on tumor-associated macrophages (TAMs) and promoting CD8+ T cell exclusion.
    Fang W, Zhou T, Shi H, Yao M, Zhang D, Qian H, Zeng Q, Wang Y, Jin F, Chai C, Chen T.
    J Exp Clin Cancer Res; 2021 Jan 04; 40(1):4. PubMed ID: 33390170
    [Abstract] [Full Text] [Related]

  • 39. Boosting anti-PD-1 therapy with metformin-loaded macrophage-derived microparticles.
    Wei Z, Zhang X, Yong T, Bie N, Zhan G, Li X, Liang Q, Li J, Yu J, Huang G, Yan Y, Zhang Z, Zhang B, Gan L, Huang B, Yang X.
    Nat Commun; 2021 Jan 19; 12(1):440. PubMed ID: 33469052
    [Abstract] [Full Text] [Related]

  • 40. Apatinib combined with PD-L1 blockade synergistically enhances antitumor immune responses and promotes HEV formation in gastric cancer.
    Zhang Y, Wang F, Sun HR, Huang YK, Gao JP, Huang H.
    J Cancer Res Clin Oncol; 2021 Aug 19; 147(8):2209-2222. PubMed ID: 33891173
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.